{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:45:47Z","timestamp":1747183547646,"version":"3.40.5"},"reference-count":24,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:p>We present a 70\u2010year\u2010old female patient diagnosed with epidermal growth factor receptor\u2010mutated metastatic non\u2010small cell lung cancer (T4N2M1a), who developed afatinib\u2010induced toxic epidermal necrolysis (TEN). We have also performed a PubMed\/Medline literature review to detect other possible cases of TEN\/Stevens\u2013Johnson syndrome associated with afatinib treatment and found only 5 other cases reported. To our best knowledge, this is the first case of afatinib\u2010induced TEN successfully treated with cyclosporine.<\/jats:p>","DOI":"10.1111\/bcp.16114","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T06:14:04Z","timestamp":1716876844000},"page":"2030-2033","source":"Crossref","is-referenced-by-count":1,"title":["Afatinib\u2010induced toxic epidermal necrolysis: A case report with a literature review"],"prefix":"10.1111","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7848-6600","authenticated-orcid":false,"given":"Andrej","family":"Belan\u010di\u0107","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology Clinical Hospital Centre Rijeka  Rijeka Croatia"},{"name":"Department of Basic and Clinical Pharmacology With Toxicology, Faculty of Medicine University of Rijeka  Rijeka Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nika","family":"Hla\u010da","sequence":"additional","affiliation":[{"name":"Department of Dermatovenerology Clinical Hospital Centre Rijeka  Rijeka Croatia"},{"name":"Department of Dermatovenerology, Faculty of Medicine University of Rijeka  Rijeka Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Peternel","sequence":"additional","affiliation":[{"name":"Department of Dermatovenerology Clinical Hospital Centre Rijeka  Rijeka Croatia"},{"name":"Department of Dermatovenerology, Faculty of Medicine University of Rijeka  Rijeka Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marin","family":"Gol\u010di\u0107","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Oncology Clinical Hospital Centre Rijeka  Rijeka Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Prpi\u0107\u2010Massari","sequence":"additional","affiliation":[{"name":"Department of Dermatovenerology Clinical Hospital Centre Rijeka  Rijeka Croatia"},{"name":"Department of Dermatovenerology, Faculty of Medicine University of Rijeka  Rijeka Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Vlahovi\u0107\u2010Pal\u010devski","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Clinical Hospital Centre Rijeka  Rijeka Croatia"},{"name":"Department of Basic and Clinical Pharmacology With Toxicology, Faculty of Medicine University of Rijeka  Rijeka Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Giotrif (afatinib) film\u2010coated tablets: EU summary of product characteristics. Accessed November 20 2023.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/giotrif"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(12)70086\u20104"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.2806"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(13)70604\u20101"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(15)00006\u20106"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1586\/era.13.30"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1010052"},{"key":"e_1_2_11_9_1","unstructured":"HALMED. \u2010Croatian agency for medicinal products and medical devices. Accessed November 20 2023.https:\/\/www.halmed.hr\/en\/"},{"key":"e_1_2_11_10_1","unstructured":"EudraVigilance database. Accessed November 20 2023.https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/pharmacovigilance\/eudravigilance"},{"key":"e_1_2_11_11_1","unstructured":"PRISMA. \u2013Transparent reporting of systematic reviews and meta\u2010analyses. Accessed November 20 2023.http:\/\/www.prisma-statement.org\/?AspxAutoDetectCookieSupport=1"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_2_11_13_1","unstructured":"Lexicomp: evidence\u2010based drug referential content. Accessed November 20 2023.https:\/\/www.wolterskluwer.com\/en\/solutions\/lexicomp"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220931926"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000914"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/978\u20103\u2010319\u201074588\u20106_195"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.901401"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13691\u2010016\u20100269\u20103"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2016.02.015"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2807"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13412"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(16)30378\u20106"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_326_20"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12758"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.5668"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.16114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T09:54:45Z","timestamp":1722333285000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.16114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1111\/bcp.16114"],"URL":"https:\/\/doi.org\/10.1111\/bcp.16114","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"type":"print","value":"0306-5251"},{"type":"electronic","value":"1365-2125"}],"subject":[],"published":{"date-parts":[[2024,5,27]]}}}